In This Section

Selected Fellow Research & Publications 

Selected Fellow Research - Header

Florence Momplaisir (July 2012-June 2014)

Momplaisir F, Fetzer B, Harhay M, Yehia B, Brady K, Long J A. HIV Testing Trends: Southeastern Pennsylvania, 2002–2010. AIDS patient care and STDs. June 2014, 28(6): 303-310.

Keller S, Yehia B, Momplaisir F, Metlay J, Brady K. Assessing the Overall Quality of Health Care in Persons Living with HIV in an Urban Environment. AIDS patient care and STDs. April 2014, 28(4): 198-205.

Keller S, Momplaisir F, Newcomb C, Liu Q, Ratcliffe S, Lo Re V, Long J. "Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection." AIDS care 26.6, 2014: 716-722.

Yehia, Baligh R., Schranz A, Momplaisir F, Keller S, Gross R, Frank I, Metlay J, Brady K. "Outcomes of HIV-Infected Patients Receiving Care at Multiple Clinics." AIDS and Behavior Sept 2013: 1-12.

Momplaisir F. HIV Update, section on PrEP; Oral presentation, Society of General Internal Medicine National Meeting, Seattle, Washington, April 2013.

Momplaisir F, Fetzer B, M, Yehia B, Brady K, Long J A. Trends of HIV testing Before and After the Introduction of Recommended Opt-Out-Testing: Southeastern Pennsylvania, 2002-2010. Poster presented at NIAID/IDSA Research Meeting, Bethesda Maryland, June 6-8, 2013

Momplaisir F, Sara Keller, Newcomb C, Liu Q, Ratcliffe S, Lo Re V, Long J. Colorectal Cancer and Screening in Medicaid Patients with and without HIV. Poster pending presentation at the national IDSA Meeting, San Francisco, California October 3, 2013.

Momplaisir F, Thompson D, Brady K, Yehia B. Time of HIV Diagnosis and Engagement in Prenatal Care Impact Outcomes in Pregnant Women with HIV. Oral presentation (abstract 303), at the 9th International Conference on HIV Treatment and Prevention Adherence, Miami, Florida, June 8-10, 2014 and the Sol Sherry Research meeting at Temple University Hospital, Philadelphia, Pennsylvania, June 11, 2014.


Purva Gumaste (July 2013-June 2015)

Gumaste P, Samuel R. Antimicrobial therapy. Chapter in ENT Essentials 1st Edition. In press.

Gumaste P., Cprek J., Farnon E. Case report: Failure of subcutaneous ivermectin in the treatment of Strongyloides hyperinfection syndrome. Mid-Atlantic Infectious Diseases Fellows’ Forum 2015. Philadelphia, PA.

Gumaste P., Patel A., Zavitsanos A., Bettiker R. Strongyloides hyperinfection mimicking endocarditis. Sol Sherry Symposium 2014. Philadelphia, PA.


Sara Schultz (July 2013-June 2015)

Schultz S, Liberator C, Clauss HE. Mediastinitis, In: Pulmonary Medicine Essentials. Criner G (ed). Springer 2019.

Schultz, S., Li S., Gallagher J. Ceftaroline in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Mid Atlantic Infectious Diseases Fellows Forum. April 20, 2015. Philadelphia, PA.

Schultz S, Momplaisir F, Jean W, Pritchard H, Jan M, Axelrod P.  Characteristics of Patients with Methicillin-resistant Staphylococcus aureus Bloodstream Infections Readmitted Within 30 Days of Hospital Discharge. Infectious Disease Society of America ID Week 2015. October 9, 2015. San Diego, CA.

Schultz S, Li SK, Gallagher JC. Ceftaroline in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Infectious Disease Society of America ID Week 2015. October 9, 2015. San Diego, CA.


Casey Godshall (July 2014-June 2016)

Casey Godshall1, Eric Sachinwalla2, John Stoeckle3, Suyin Chi4, Rafik Samuel1, Heather Clauss1, and Robert L. Bettiker1  Section of Infectious Diseases, Temple University Hospital, Philadelphia, PA; 2Division of Infectious Diseases, Einstein Medical Center, Philadelphia, PA; 3Department of Family Medicine, Thomas Jefferson University Hospital, Philadelphia, PA; 4Franciscan Medical Specialists, Valparaiso, IN.  “Undiagnosed
Hepatitis C Viremia in an Inner City Hospital.”  Sol Sherry Research Symposium, June 2016.  Best Fellow Research Award Winner


Daniel Mueller (July 2014-June 2016)

Cheung JY, Mueller DJ, et al. A Longitudinal Crossover Study of Re-structuring Medicine Inpatient Teaching Service: Improved Continuity of Care within the Constraint of 2011 Duty Hour Regulations.  Healthcare 3(2015)

Daniel Mueller, MD and Rafik Samuel, MD.  “Healthcare-Associated Pneumonias.” Pulmonary Medicine Essentials. Editor: Gerald Criner. 

Mueller DJ. Retrospective Analysis of Infective Endocarditis at an Urban Hospital.  Poster Presentation.  ID Week (Infectious Diseases Society of America), Philadelphia, PA.  October 2014


Esther Molnar (July 2015-June 2017)

Anesi J, Han J, Lautenbach E, Lee D, Clauss H, Climaco A, Bilker W, Hasz R, Molnar E, Alimenti D, West S, Tolomeo P, Blumberg E for the CDC Prevention Epicenters Program.  Impact of deceased donor multidrug-resistant bacterial organisms on organ utilization.  American Journal of Transplantation Feb 2020.  doi: 10.1111/ajt.15830 [PMID 32091403]

Anesi J, Blumberg E, Han J, Lee D, Clauss H, Climaco A, Hasz R, Molnar E, Alimenti D, West S, Bilker WB, Tolomeo P, Lautenbach E for the CDC Prevention Epicenters Program.  Risk factors for multidrug-resistant organisms among deceased organ donors.  American Journal of Transplantation 2019.  Cover Article.  doi: 10.1111/ajt.15488.  [PMID:  31162785]

Anesi J, Blumberg E, Han J, Lee D, Clauss H, Climaco A, Hasz R, Molnar E, Alimenti D, West S, Bilker WB, Tolomeo P, Lautenbach E.  Clinical Prediction Tool for Multidrug-Resistant Organisms among Deceased Donors at the Time of Donor Evaluation.  Poster Presentation at ID Week:  Washington DC, Oct 2019.


Devin Weber (July 2015-June 2017)

Weber, D. Fallis, R. Axelrod, P.  “Ceftaroline versus vancomycin +/- daptomycin for MRSA endocarditis.” Temple University Department of Medicine Sol Sherry Research Symposium. Oral presentation. June 7, 2017.  *Second prize winner for fellow research


Abdul Elabor (July 2016-June 2018)

Elabor A, Molnar E, King M, Gallagher J, and TOL-TAZ for Resistant Pseudomonas Study Group. “Ceftolozane/tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study.”  ID Week.  San Francisco 2018. 


Joseph DeRose (July 2017-June 2019)

DeRose J, Axelrod P, Samuel R, Clauss, H.  Risk Factors for Clostridium difficile Infection in Lung Transplant Patients.  Poster Presentation at ID Week; Washington DC, Oct 2019.


Rebecca Fallis (July 2017-June 2019)

Fallis R, and Mueller D. “Epididymo-orchitis.” Clinical Infectious Disease, 3rd Edition. Oxford University Press. Editor: David Schlossberg. (Awaiting Publication)

Fallis R, Jablonski L, Moss S, Axelrod P, Clauss H.  Infectious complications of bronchial stenosis in lung transplant recipients. Transplant Infectious Disease. 2019; e13100.  https://doi.org/10.1111/tid.13100.  [PMID: 31056837]

Fallis, R.J., Burnell, J., Axelrod, P., Mueller, D. Risk factors associated with Extended Spectrum Beta-Lactamase (ESBL) Bacteremia. Sol Sherry Research Symposium at Temple University Hospital. June 5., 2019; Philadelphia, PA.

Fallis, R.J., Samuel, R., Bettiker, R. Screening for Extragenital Gonorrhea and Chlamydia in Men who have Sex with Men (MSM) at an Urban HIV Clinic. Sol Sherry Research Symposium at Temple University Hospital. June 5, 2019; Philadelphia, PA.

Fallis, R.J., Weber D., Axelrod, P., Gallagher, J. Ceftaroline Compared to Standard Treatment for MRSA Endocarditis.  3rd Mid-Atlantic ID Fellow’s Forum at the Hospital of the University of Pennsylvania. April 13, 2018; Philadelphia, PA.